Orion - Decisions of general meeting

Orion Oyj : Decisions by the AGM on 20 March 2012

ORION CORPORATION STOCK EXCHANGE RELEASE 20 March 2012 at 04.30 pm  EET

Orion Corporation: Decisions by the AGM on 20 March 2012

At the Annual General Meeting of Orion Corporation held today, the following
decisions were made:
  * A dividend of EUR 1.30 per share was confirmed to be paid for 2011.
    Additionally, EUR 0.12 per share was confirmed to be paid to the
    shareholders as a repayment of capital. The record date for the dividend
    payment and the repayment of capital is 23 March 2012 and the payment date
    is 4 April 2012.
  * The proposals concerning the election and remuneration of the Board of
    Directors and the auditor were approved.
  * Sirpa Jalkanen, Eero Karvonen, Hannu Syrjänen, Heikki Westerlund and Jukka
    Ylppö were re-elected to the Board of Directors. Timo Maasilta was elected
    as a new member. Hannu Syrjänen was re-elected as Chairman.



The Annual General Meeting of Orion Corporation was held today in Helsinki. The
following matters were handled at the meeting:

Adoption of the Financial Statements for 1 January - 31 December 2011
The AGM confirmed the Financial Statements of the parent company and the Group
as per 31 December 2011.

Dividend EUR 1.30 per share
A dividend of EUR 1.30 per share was approved. The record date for the dividend
payment is 23 March 2012 and the payment date is 4 April 2012.

EUR 0.12 per share as a repayment of capital
EUR 0.12 per share was decided to be distributed to the shareholders from the
reserve for invested unrestricted equity as a repayment of capital. The record
date for the repayment is 23 March 2012 and the payment date is 4 April 2012.

Discharge from liability
The members of the Board of Directors and the President and CEO were discharged
from liability for the financial period of 1 January - 31 December 2011.

Remunerations to be paid to the Board of Directors
As an annual fee for the term of office of the Board of Directors, the Chairman
shall receive
EUR 76,000, the Vice Chairman shall receive EUR 51,000 and the other members
shall receive EUR 38,000 each. As a fee for each meeting attended, the Chairman
shall receive EUR 1,200, the Vice Chairman shall receive EUR 900 and the other
members shall receive EUR 600 each. The travel expenses of all Board members
shall be paid in accordance with previously adopted practice. The afore-
mentioned fees for each committee meeting attended shall also be paid to the
Chairmen and to the members of the committees established by the Board.

Of the annual fee, 60% shall be paid in cash and 40% in Orion Corporation B-
shares, which shall be acquired to the members during 26-30 March 2012 from the
stock exchange in amounts corresponding to EUR 30,400 for the Chairman, EUR
20,400 for the Vice Chairman and EUR 15,200 for each of the other members. The
part of the annual fee that is to be paid in cash corresponds to the approximate
sum necessary for the payment of the income taxes on the fees and shall be paid
no later than 30 April 2012. The annual fees encompass the full term of office
of the Board of Directors.

Timo Maasilta elected as new member to the Board of Directors.
Hannu Syrjänen re-elected as Chairman
The number of members in the Board of Directors was confirmed to be six. Sirpa
Jalkanen, Eero Karvonen, Hannu Syrjänen, Heikki Westerlund and Jukka Ylppö were
re-elected, and Timo Maasilta was elected as a new member to the Board of
Directors for the next term of office. Hannu Syrjänen was re-elected as
Chairman.

Auditor and their remuneration
PricewaterhouseCoopers Oy, authorised public accountants, were re-elected as the
Company's auditor. The remunerations to the Auditor shall be paid on the basis
of invoicing approved by the Company.


The minutes of the AGM will be provided in Finnish only, and they will become
available on Orion's internet website, address www.orion.fi/agm2012, no later
than 3 April 2012.



Orion Corporation

 Timo Lappalainen  Olli Huotari
 President and CEO SVP, Corporate Functions


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler(®) pulmonary drugs.

Orion's net sales in 2011 amounted to EUR 918 million and the company had about
3,400 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.



[HUG#1595831]